Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Occlusion-AF: LAAO vs NOAC for Stroke Prevention in AF
NCT03642509Recruiting
- Sponsor
- Aarhus University
- Start
- Jan 2019
- Primary completion
- Jan 2026
- Countries
- 5
01
Overview
Randomised, open-label trial (2 arms), sponsored by Aarhus University. Primary endpoint: Composite endpoint of stroke (ischemic and hemorrhagic), systemic embolism, major bleeding and all-cause mortality at 5 years. Started Jan 2019; status: recruiting.
Beyond the preview
Go deeper on NCT03642509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03642509.